Commentary · 8 Jun 2026
Conference abstractPublished 16 Feb 2019
Differentiating Parkinson’s dementia from other types of dementia
Icahn School of Medicine at Mt Sinai, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diagnosis of Parkinson’s dementia is mostly clinical. However, there are many forms of demetia. Treatment approach of some forms of demetia is different from those of the Parkinson’s type. For example dementia due to Alzheimer’s disease are dependent on acetyl choline neurotransmission while Parkinson’s demetia is due to dysregulated dopamine neurotransmission. Because of subjective nature of clinical diagnosis, many patients are misdiagnosed with a different type of dementia, resulting in patients receiving wrong treatment. It is therefore important to have a diagnostic method that allows us to differentiate dopamine and acetyl choline dependent dementia. A novel neuroimaging technique that we recently developed could be useful in this context. The technique called single scan dynamic molecular imaging technique (SDMIT) uses positron emission tomography (PET) to detect, map and measure dopamine released acutely during cognitive or behavioral processing. It exploits the competition between a neurotransmitter and its receptor ligand for occupancy of the same receptor site. In this technique after patients are positioned in the PET camera, a radio-labeled neurotransmitter ligand is injected intravenously and the PET data acquisition started. These data are used by a receptor kinetic model to detect, map and measure neurotransmitter released dynamically in different brain areas. Patients are asked to perform a cognitive task while in the scanner and the amount of neurotransmitter released in different brain areas measured. By comparing it with the data acquired in age-matched healthy volunteers during performance of a similar task, it is possible to determine which neurotransmitter release is dysregulated in the patients and whether the dysregulation is responsible for clinical symptoms. Finding of a significant dysregulation of dopaminergic neurotransmission would indicate a diagnosis of Parkinson’s dementia while dysregulated acetyl choline neurotransmission would suggest dementia of Alzheimer’s type.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Rajendra D Badgaiyan”